| Purpose | Announcement Date | Right Issue Date | Record Date | Rights Ratio | Premium | Remark |
|---|---|---|---|---|---|---|
| Rights | 6 Aug 2026 | 10 Aug 2026 | 10 Aug 2026 | 1:1 | 25 | 1:1 Rights Issue Of Equity Shares |
| 1:1 Rights Issue Of Equity Shares | ||||||
| Rights | 19 Mar 2026 | 23 Mar 2026 | 23 Mar 2026 | 1:1 | 25 | 1:1 Right issue Of Equity Shares |
| 1:1 Right issue Of Equity Shares Sunrest Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on April 30, 2026 for Dissolving the Right Issue and other matters. The board has decided to dissolve the right issue and unblock the fund of the applicants, due to non-receipt of minimum subscription as per the terms of the issue and Regulation 86 of the SEBI(Issue of Capital and Disclosure Requirements)Regulations, 2018 (As Per NSE Announcement Dated On : 30.04.2026) | ||||||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
